EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 23 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,196 | +20.6% | 202,371 | +65.5% | 0.00% | 0.0% |
| Q4 2022 | $6,797 | +35.9% | 122,257 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 122,257 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $8,000 | -77.1% | 122,257 | -34.7% | 0.00% | -66.7% |
| Q1 2022 | $35,000 | -66.0% | 187,227 | +5.0% | 0.00% | -66.7% |
| Q4 2021 | $103,000 | +281.5% | 178,347 | +375.9% | 0.01% | +800.0% |
| Q3 2021 | $27,000 | -30.8% | 37,478 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $39,000 | -35.0% | 37,478 | -21.8% | 0.00% | -50.0% |
| Q1 2021 | $60,000 | – | 47,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 66,666 | $660,000 | 0.02% |
| Radcliffe Capital Management, L.P. | 33,333 | $330,000 | 0.01% |
| Altium Capital Management LP | 133,333 | $9,000 | 0.00% |
| Arena Investors LP | 94,516 | $6,000 | 0.00% |
| Granite Point Capital Management, L.P. | 133,332 | $9,000 | 0.00% |
| COWEN AND COMPANY, LLC | 122,257 | $8,000 | 0.00% |
| 683 Capital Management, LLC | 200,000 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GLAZER CAPITAL, LLC | 11,584 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 26,666 | $2,000 | 0.00% |